554 related articles for article (PubMed ID: 27612551)
21. Cardiovascular involvement in rheumatoid arthritis.
Gerli R; Goodson NJ
Lupus; 2005; 14(9):679-82. PubMed ID: 16218466
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular morbidity and mortality in rheumatoid arthritis.
Gabriel SE
Am J Med; 2008 Oct; 121(10 Suppl 1):S9-14. PubMed ID: 18926169
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
Choy E; Ganeshalingam K; Semb AG; Szekanecz Z; Nurmohamed M
Rheumatology (Oxford); 2014 Dec; 53(12):2143-54. PubMed ID: 24907149
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular disease in rheumatoid arthritis: a step forward.
Myasoedova E; Gabriel SE
Curr Opin Rheumatol; 2010 May; 22(3):342-7. PubMed ID: 20164773
[TBL] [Abstract][Full Text] [Related]
25. Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients.
Santos MJ; Pedro LM; Canhão H; Fernandes E Fernandes J; Canas da Silva J; Fonseca JE; Saldanha C
Atherosclerosis; 2011 Dec; 219(2):821-6. PubMed ID: 21906736
[TBL] [Abstract][Full Text] [Related]
26. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.
Mahmoudi M; Aslani S; Fadaei R; Jamshidi AR
Int J Rheum Dis; 2017 Mar; 20(3):287-297. PubMed ID: 28205331
[TBL] [Abstract][Full Text] [Related]
27. Lipid profile and risks of cardiovascular diseases in conditions of rheumatoid arthritis.
Pašková U
Ceska Slov Farm; 2019; 68(6):219-228. PubMed ID: 31906689
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
29. Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up.
Tournadre A; Pereira B; Dubost JJ; Rincheval N; Rat AC; Combe B; Soubrier M
Clin Exp Rheumatol; 2017; 35(2):296-302. PubMed ID: 28079508
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk in patients with rheumatoid arthritis.
Lauper K; Gabay C
Semin Immunopathol; 2017 Jun; 39(4):447-459. PubMed ID: 28455580
[TBL] [Abstract][Full Text] [Related]
31. Atherogenesis in rheumatoid arthritis: the "rheumatoid vasculopathy"?
Fietta P; Delsante G
Acta Biomed; 2009; 80(3):177-86. PubMed ID: 20578409
[TBL] [Abstract][Full Text] [Related]
32. Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.
Gerli R; Sherer Y; Bocci EB; Vaudo G; Moscatelli S; Shoenfeld Y
Ann N Y Acad Sci; 2007 Jun; 1108():372-81. PubMed ID: 17894000
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice.
Giles JT
Best Pract Res Clin Rheumatol; 2015; 29(4-5):597-613. PubMed ID: 26697769
[TBL] [Abstract][Full Text] [Related]
34. Incidence and predictors of cardiovascular events in a cohort of patients with rheumatoid arthritis.
Castro AM; Carmona-Fernandes D; Rodrigues AM; Pedro LM; Santos MJ; Canhão H; Fonseca JE
Acta Reumatol Port; 2016; 41(3):213-219. PubMed ID: 27682808
[TBL] [Abstract][Full Text] [Related]
35. The impact of cardiorespiratory fitness on classical cardiovascular disease risk factors in rheumatoid arthritis: a cross-sectional and longitudinal study.
Cooney JK; Ahmad YA; Moore JP; Sandoo A; Thom JM
Rheumatol Int; 2019 Oct; 39(10):1759-1766. PubMed ID: 31482199
[TBL] [Abstract][Full Text] [Related]
36. Effects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis.
Toussirot É
Expert Opin Drug Saf; 2015 Apr; 14(4):525-32. PubMed ID: 25599626
[TBL] [Abstract][Full Text] [Related]
37. Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance.
Mavrogeni S; Dimitroulas T; Bucciarelli-Ducci C; Ardoin S; Sfikakis PP; Kolovou G; Kitas GD
Inflamm Allergy Drug Targets; 2014; 13(2):81-93. PubMed ID: 24479835
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.
Crowson CS; Matteson EL; Roger VL; Therneau TM; Gabriel SE
Am J Cardiol; 2012 Aug; 110(3):420-4. PubMed ID: 22521305
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular risk and rheumatoid arthritis--the next step: differentiating true soluble biomarkers of cardiovascular risk from surrogate measures of inflammation.
Kozera L; Andrews J; Morgan AW
Rheumatology (Oxford); 2011 Nov; 50(11):1944-54. PubMed ID: 21752870
[TBL] [Abstract][Full Text] [Related]
40. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.
Södergren A; Karp K; Bengtsson C; Möller B; Rantapää-Dahlqvist S; Wållberg-Jonsson S
J Rheumatol; 2015 Jun; 42(6):935-42. PubMed ID: 25877503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
